Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
Published on: August 2, 2024
Unmet needs and future perspectives in hydroxychloroquine retinopathy
Imran H Yusuf1, Peter Charbel Issa1, Seong Joon Ahn2
1Oxford Eye Hospital and Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Early detection of hydroxychloroquine retinopathy is crucial for preventing vision loss but remains challenging. This article highlights current knowledge gaps and unmet needs in screening and research for this toxic effect.
Area of Science:
- Ophthalmology
- Pharmacology
- Toxicology
Background:
- Hydroxychloroquine (HCQ) treatment can cause retinopathy, a serious toxic effect.
- Early detection of HCQ retinopathy is vital to prevent irreversible vision loss.
- Current screening methods face challenges in identifying early-stage HCQ retinopathy.
Purpose of the Study:
- To summarize existing knowledge gaps in hydroxychloroquine retinopathy.
- To identify unmet needs in clinical practice and research.
- To guide future directions for screening and research.
Main Methods:
- Perspective article.
- Literature review and synthesis of current clinical practices and research.
- Identification of challenges in early detection and management.
Main Results:
- Significant challenges persist in the early detection of hydroxychloroquine retinopathy.
- There is a lack of established treatments beyond drug cessation.
- Knowledge gaps exist regarding optimal screening protocols and understanding the disease mechanism.
Conclusions:
- Further research is needed to improve early detection and understanding of hydroxychloroquine retinopathy.
- Addressing unmet needs in clinical practice is essential for better patient outcomes.
- This perspective aims to inform and direct future efforts in managing HCQ toxicity.
More Related Videos
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
09:33An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
Published on: September 13, 2016
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Nephrotic Syndrome II : Assessment and Medical Management